This indicates that the hepatoprotective and lipid-lowering effects of TLSP in C57BL/6J mice with HFD-induced hyperlipidemia might be partially attributable to an increase in antioxidant enzyme activities [53, 54]. Here, KLK11 is linked to hyperlipidemia.